Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001493152-21-006920
Filing Date
2021-03-26
Accepted
2021-03-26 16:15:53
Documents
12

Document Format Files

Seq Description Document Type Size
1 formf-3.htm F-3 754867
2 image_001.jpg GRAPHIC 12006
3 ex1-2.htm EX-1.2 316094
4 ex4-4.htm EX-4.4 328307
5 ex4-5.htm EX-4.5 345529
6 ex5-1.htm EX-5.1 41159
7 ex23-1.htm EX-23.1 4440
8 ex5-1_001.jpg GRAPHIC 7908
9 ex5-2.htm EX-5.2 23781
10 ex5-2_001.jpg GRAPHIC 3358
11 ex5-2_002.jpg GRAPHIC 6208
12 ex5-2_003.jpg GRAPHIC 2875
  Complete submission text file 0001493152-21-006920.txt   1860282
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-254766 | Film No.: 21777599
SIC: 2834 Pharmaceutical Preparations